Showing results (1-10 of 233) with videos related to
Sort By:
Pageof 24
Advances in Experimental Medicine and Biology|March 23, 2012
Physiologically-based pharmacokinetic (PBPK) models in toxicity testing and risk assessmentJohn C Lipscomb, Sami Haddad, Torka Poet, et al.Journal of Toxicology and Environmental Health. Part A|April 26, 2003
Physiological modeling of age-specific changes in the pharmacokinetics of organic chemicals in childrenKarine Price, Sami Haddad, Kannan KrishnanEnvironmental Health Perspectives|March 14, 2003
Physiological modeling and extrapolation of pharmacokinetic interactions from binary to more complex chemical mixturesKannan Krishnan, Sami Haddad, Martin Béliveau, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|October 14, 2017
Extrapolation of plasma clearance to understand species differences in toxicokinetics of bisphenol ATorka Poet, Sean HaysInternational Journal of Hygiene and Environmental Health|October 18, 2015
Deriving Biomonitoring Equivalents for selected E- and P-series glycol ethers for public health risk assessmentTorka Poet, Nicholas Ball, Sean M HaysRegulatory Toxicology and Pharmacology : RTP|March 29, 2013
Case study illustrating the WHO IPCS guidance on characterization and application of physiologically based pharmacokinetic models in risk assessmentM E Bette Meek, Hugh A Barton, Jos G Bessems, et al.Toxicology Mechanisms and Methods|December 22, 2009
Incorporation of pharmacokinetic and pharmacodynamic data into risk assessmentsJohn C Lipscomb, M E Bette Meek, Kannan Krishnan, et al.Journal of Toxicology and Environmental Health. Part B, Critical Reviews|June 28, 2008
Approaches for applications of physiologically based pharmacokinetic models in risk assessmentChad M Thompson, Babasaheb Sonawane, Hugh A Barton, et al.Journal of Applied Toxicology : JAT|February 15, 2007
Evaluation of physiologically based pharmacokinetic models for use in risk assessmentWeihsueh A Chiu, Hugh A Barton, Robert S DeWoskin, et al.Pageof 24